C3 and obesity disorder: In humans, the increased expression of complement system genes, especially C3, has been correlated with metabolic dysfunction, including insulin resistance, inflammation, obesity, and diabetes (Engström et al., 2005; Barbu et al., 2015; Moreno-Navarrete and Fernández-Real, 2019).